Vencanna Ventures Inc
VENI
Critical Reagent Processing Corp
CRPC
Sanu Gold Corp
SANU
Cannibble Food Tech Ltd
PLCN
Fineqia International Inc
FNQ
CA Stock MarketDetailed Quotes
METX ME Therapeutics Holding Inc
- 4.000
- +0.200+5.26%
15min DelayMarket Closed Dec 2 14:32 ET
100.76MMarket Cap-80000P/E (TTM)
4.000High3.900Low3.01KVolume4.000Open3.800Pre Close11.79KTurnover7.50052wk High0.03%Turnover Ratio25.19MShares0.75052wk Low-0.05EPS TTM44.17MFloat Cap7.500Historical HighLossP/E (Static)11.04MShs Float0.050Historical Low-0.05EPS LYR2.63%Amplitude--Dividend TTM67.80P/B1Lot Size--Div YieldTTM
ME Therapeutics Holding Inc Key Stats
Quarterly+Annual
YOY
| (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q1)Dec 31, 2022 | (FY)Aug 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -117.00%-657.92K | -48.92%-150.26K | 2.58%-142.98K | -99.25K | -1,078.96%-265.43K | -123.46%-303.2K | -100.9K | -146.77K | -22.51K | -135.69K |
| Net income from continuing operations | 80.14%-1.29M | 89.41%-312.04K | 85.81%-495.99K | ---143.49K | -431.40%-343.11K | -4,372.64%-6.52M | ---2.95M | ---3.49M | ---64.57K | ---145.78K |
| Depreciation and amortization | -20.41%39 | -25.00%9 | -16.67%10 | --11 | --9 | -19.67%49 | --12 | --12 | ---- | --61 |
| Remuneration paid in stock | 17.45%690.89K | -31.20%170.87K | -10.11%305.5K | --6.92K | --207.6K | 4,198.90%588.22K | --248.35K | --339.87K | ---- | --13.68K |
| Other non cashItems | -99.85%8.58K | --0 | -99.96%1.25K | --2.93K | --4.4K | 51,625.44%5.59M | --2.58M | --2.99M | ---- | --10.8K |
| Change In working capital | -247.48%-62.8K | -165.85%-9.1K | 129.20%46.25K | --34.38K | -419.42%-134.33K | 394.77%42.58K | --13.82K | --20.18K | --42.05K | ---14.45K |
| -Change in receivables | -160.76%-9.37K | -239.08%-3.52K | -228.20%-5.05K | --22.98K | ---23.78K | 175.05%15.42K | ---1.04K | ---1.54K | ---- | ---20.55K |
| -Change in prepaid assets | 47.87%-7.87K | -41.89%-21.74K | -81.57%4.55K | --49.95K | ---40.63K | -583.97%-15.1K | ---15.32K | --24.7K | ---- | ---2.21K |
| -Change in payables and accrued expense | -207.80%-45.56K | -46.42%16.17K | 1,665.61%46.75K | ---38.56K | -266.26%-69.92K | 408.48%42.26K | --30.18K | ---2.99K | --42.05K | --8.31K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -117.00%-657.92K | -48.92%-150.26K | 2.58%-142.98K | ---99.25K | -1,078.96%-265.43K | -123.46%-303.2K | ---100.9K | ---146.77K | ---22.51K | ---135.69K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 757.44K | 0 | 0 | |||||
| Net business purchase and sale | --0 | --0 | ---- | ---- | ---- | --757.44K | --0 | ---- | ---- | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | ---- | ---- | ---- | --757.44K | --0 | ---- | ---- | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,204.91%1.51M | -106.49%-7.5K | 450K | -17.48%115.53K | 115.53K | 0 | 125K | 140K | ||
| Net issuance payments of debt | ---40K | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | --140K |
| Net common stock issuance | 1,246.03%1.56M | --0 | ---- | ---- | ---- | --115.53K | ---- | ---- | --125K | --0 |
| Proceeds from stock option exercised by employees | ---7.5K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,204.91%1.51M | -106.49%-7.5K | --450K | ---- | ---- | -17.48%115.53K | --115.53K | --0 | --125K | --140K |
| Net cash flow | ||||||||||
| Beginning cash position | 736.35%647.15K | 161.57%1.65M | 6,066.33%1.35M | --381.72K | 62.64%647.15K | 5.91%77.38K | --632.52K | --21.85K | --397.91K | --73.06K |
| Current changes in cash | 49.11%849.58K | -1,178.77%-157.76K | -49.72%307.02K | --965.75K | -358.99%-265.43K | 13,104.36%569.77K | --14.62K | --610.67K | --102.49K | --4.32K |
| End cash Position | 131.28%1.5M | 131.28%1.5M | 161.57%1.65M | --1.35M | -23.72%381.72K | 736.35%647.15K | --647.15K | --632.52K | --500.4K | --77.38K |
| Free cash from | -117.00%-657.92K | -48.92%-150.26K | 2.58%-142.98K | ---99.25K | -1,078.96%-265.43K | -123.46%-303.2K | ---100.9K | ---146.77K | ---22.51K | ---135.69K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.